A carregar...

Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost Effectiveness and Health Impact in U.S. Populations

INTRODUCTION: Recommending both the conjugate and polysaccharide pneumococcal vaccines to all U.S. seniors may have little public health impact and be economically unreasonable. Public health impact and cost effectiveness of using both vaccines in all adults aged ≥65 years were estimated compared wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Prev Med
Main Authors: Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7089827/
https://ncbi.nlm.nih.gov/pubmed/32001052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2019.10.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!